Diabetes Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Induced pluripotent stem (IPS) celssAs part of the effort to understand the development of genetic diseases, Boston Children’s has created induced pluripotent stem (iPS) cells, which are cells taken from patients and reprogrammed to look and function like embryonic stem cells. Scientists use these iPS cells to model the genetic diseases of the patients from whom they were taken, including Type I diabetes patients.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944